IN8bio Inc.

NASDAQ: INAB · Real-Time Price · USD
2.35
-0.05 (-2.08%)
At close: Aug 15, 2025, 3:59 PM
2.29
-2.55%
After-hours: Aug 15, 2025, 06:39 PM EDT

IN8bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
2.53M 2.53M 2.53M 3.75M 3.75M 3.75M 3.75M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
2.88M 3.01M 3.22M 2.58M 2.54M 2.54M 1.91M 1.64M 1.23M 871K 1.1M 841K 652K 378K 311K 222K 187K 187K
Gross Profit
-2.32M -2.45M -2.65M 1.17M 1.21M 1.21M 1.84M -1.64M -1.23M -871K -1.1M -841K -652K -378K -311K -222K -187K -187K
Operating Income
-23.95M -27.49M -30.5M -32.2M -32.29M -31.37M -30.34M -30.21M -30.44M -29.9M -28.52M -26.57M -22.56M -18.43M -14.65M -11.12M -9.4M -9.23M
Interest Income
304K 257K 230K 166K 143K 83K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-23.89M -27.43M -30.44M -31.88M -31.96M -31.04M -30.01M -30.21M -30.44M -29.9M -28.52M -26.57M -22.56M -18.43M -14.65M -11.12M -9.4M -9.23M
Net Income
-23.89M -27.43M -30.44M -31.88M -31.96M -31.04M -30.01M -30.21M -30.44M -29.9M -28.52M -26.57M -22.56M -18.43M -14.65M -11.12M -9.4M -9.23M
Selling & General & Admin
10.76M 11.58M 12.64M 12.46M 13.11M 13.15M 12.88M 14.31M 14.07M 14.16M 14.46M 13.74M 12.64M 9.95M 7.31M 4.97M 3.55M 3.66M
Research & Development
12.36M 15.03M 16.96M 17.89M 18.37M 17.34M 16.83M 16.23M 16.7M 16.07M 14.06M 12.83M 9.92M 8.48M 7.35M 6.14M 5.85M 5.57M
Other Expenses
616K 556K 902K 1.86M 814K 874K 627K -330K -330K -330K n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
23.74M 27.17M 30.5M 32.2M 32.29M 31.37M 30.34M 30.21M 30.44M 29.9M 28.52M 26.57M 22.56M 18.43M 14.65M 11.12M 9.4M 9.23M
Interest Expense
n/a n/a n/a 590K 590K 590K 590K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a -627K -627K -627K -627K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
25.43M 28.86M 31.76M 32.2M 32.29M 31.37M 30.34M 30.21M 30.44M 29.9M 28.52M 26.57M 22.56M 18.43M 14.65M 11.12M 9.4M 9.23M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
4.12B 83.48M 72.48M 47.32M 45.13M 43.29M 35.8M 31.55M 28.47M 24.73M 24.55M 21.66M 18.83M 18.8M 18.78M 18.75M 18.75M 19.35M
Shares Outstanding (Diluted)
4.12B 83.48M 72.48M 47.32M 45.13M 43.29M 35.8M 31.55M 28.47M 24.73M 24.55M 21.66M 18.83M 18.8M 18.78M 18.75M 18.75M 19.35M
EPS (Basic)
-1.54 -0.49 -0.62 -0.75 -0.83 -0.91 -1.01 -1.12 -1.23 -1.34 -1.37 -1.36 -1.2 -0.98 -0.77 -0.58 -0.49 -0.52
EPS (Diluted)
-1.54 -0.49 -0.62 -0.75 -0.83 -0.91 -1.01 -1.12 -1.23 -1.34 -1.37 -1.36 -1.2 -0.98 -0.77 -0.58 -0.49 -0.52
EBITDA
-21.45M -24.42M -26.88M -28.72M -29.89M -28.91M -27.84M -27.98M -28.61M -28.44M -27.42M -25.73M -21.91M -17.87M -14.15M -10.68M -9.01M -9M
EBIT
-23.02M -26.61M -29.6M -31.3M -32.43M -31.46M -30.34M -30.21M -30.44M -29.9M -28.52M -26.57M -22.56M -18.43M -14.65M -11.12M -9.4M -9.23M
Depreciation & Amortization
1.82M 2.45M 2.65M 2.58M 2.54M 2.54M 2.5M 2.23M 1.82M 1.46M 1.1M 841K 652K 568K 501K 434K 399K 231K